Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) announced a monthly dividend on Thursday, July 9th. Investors of record on Monday, September 14th will be paid a dividend of 0.1017 per share by the real estate investment trust on Friday, September 25th. This represents a c) annualized dividend and a yield of 5.6%. The ex-dividend date of this dividend is Monday, September 14th.
Healthpeak Properties has decreased its dividend payment by an average of 0.0%per year over the last three years. Healthpeak Properties has a payout ratio of 369.7% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect Healthpeak Properties to earn $1.77 per share next year, which means the company should continue to be able to cover its $1.22 annual dividend with an expected future payout ratio of 68.9%.
Healthpeak Properties Trading Down 0.8%
NYSE:DOC opened at $21.59 on Friday. The business’s 50-day moving average is $19.98 and its two-hundred day moving average is $18.00. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. Healthpeak Properties has a 12 month low of $15.70 and a 12 month high of $22.13. The firm has a market capitalization of $14.89 billion, a PE ratio of 67.49, a price-to-earnings-growth ratio of 3.38 and a beta of 1.02.
Insider Activity
In related news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.23% of the company’s stock.
Institutional Investors Weigh In On Healthpeak Properties
A number of hedge funds have recently bought and sold shares of DOC. CX Institutional increased its holdings in Healthpeak Properties by 6.1% during the 2nd quarter. CX Institutional now owns 11,003 shares of the real estate investment trust’s stock worth $235,000 after purchasing an additional 633 shares during the last quarter. Fiduciary Trust Co boosted its stake in shares of Healthpeak Properties by 4.9% during the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock valued at $264,000 after buying an additional 644 shares during the last quarter. Patton Fund Management Inc. boosted its stake in shares of Healthpeak Properties by 5.2% during the 4th quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock valued at $209,000 after buying an additional 648 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Healthpeak Properties by 1.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after buying an additional 718 shares during the last quarter. Finally, Quantum Portfolio Management LLC grew its position in shares of Healthpeak Properties by 2.5% during the first quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust’s stock worth $483,000 after buying an additional 728 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- PepsiCo’s Dividend Could Turn Patience Into Real Profit
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
